Oncolytic vaccinia virus: a silver bullet?

References

• Ramalingam S, Belani C. Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. Oncologist13(Suppl. 1), 5–13 (2008).
   PubMed Web of Science ®Google Scholar
• Simmons O, Magee M, Nemunaitis J. Current vaccine updates for lung cancer. Expert Rev. Vaccines9(3), 323–335 (2010).
   PubMed Web of Science ®Google Scholar
• Coley W. Late results of the treatment of inoperable sarcoma by the mixed toxins of Erysipelas and Bacillus prodigiosus. Am. J. Med. Sci.131, 375–428 (1906).
   Google Scholar
• Newman W, Southam CM. Virus treatment in advanced cancer. A pathological study of fifty seven cases. Cancer7(1), 106–118 (1954).
   PubMed Web of Science ®Google Scholar
• Kelly E, Russell SJ. History of oncolytic viruses: genesis to genetic engineering. Mol. Ther.15(4), 651–659 (2007).
   PubMed Web of Science ®Google Scholar
• Cassel WA, Murray DR. A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate. Med. Oncol. Tumor Pharmacother.9(4), 169–171 (1992).
   PubMedGoogle Scholar
• Scoggin SD, Sivanandham M, Sperry RG, Wallack MK. Active specific adjuvant immunotherapy with vaccinia melanoma oncolysate. Ann. Plast. Surg.28(1), 108–109 (1992).
   PubMed Web of Science ®Google Scholar
• Park BH, Hwang T, Liu TC et al. Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a Phase I trial. Lancet Oncol.9(6), 533–542 (2008).
   PubMed Web of Science ®Google Scholar
• Kirn DH, Thorne SH. Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer. Nat. Rev. Cancer9(1), 64–71 (2009).
   PubMed Web of Science ®Google Scholar
• Smith GL, Moss B. Infectious poxvirus vectors have capacity for at least 25,000 base pairs of foreign DNA. Gene25(1), 21–28 (1983).
   PubMed Web of Science ®Google Scholar
• Mackett M, Smith GL, Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol.49(3), 857–864 (1984).
   PubMed Web of Science ®Google Scholar
• Buller R, Smith GL, Cremer K, Notkins AL, Moss B. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature317, 813–815 (1985).
   PubMed Web of Science ®Google Scholar
• Kaplan C. Vaccinia virus: a suitable vehicle for recombinant vaccines? Arch. Virol.106(1–2), 127–139 (1989).
   PubMed Web of Science ®Google Scholar
• Acres B, Dott K, Stefani L, Kieny MP. Directed cytokine expression in tumor cells in vivo using recombinant vaccinia virus. Ther. Immunol.1(1), 17–23 (1994).
   PubMedGoogle Scholar
• Acres B, Stefani L, Dott K, Kieny MP. Delivery of cytokine genes to tumor cells in vivo using recombinant vaccinia virus vectors – cytokine cDNA gene expression in vaccinia virus vector; tumor-bearing mouse injection for potential cancer cytokine-mediated gene therapy (conference abstract). Cancer Gene Ther.1(4), 308 (1994).
   Web of Science ®Google Scholar
• Gahéry-Ségard H, Molinier-Frenkel V, Le Boulaire C et al. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products. J. Clin. Invest.100(9), 2218–2226 (1997).
   PubMed Web of Science ®Google Scholar
• Worschech A, Haddad D, Stroncek DF, Wang E, Marincola FM, Szalay AA. The immunologic aspects of poxvirus oncolytic therapy. Cancer Immunol. Immunother.58(9), 1355–1362 (2009).
   PubMed Web of Science ®Google Scholar
• Grem JL. 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development. Invest. New Drugs18(4), 299–313 (2000).
   PubMed Web of Science ®Google Scholar
• Noordhuis P, Holwerda U, van der Wilt CL et al. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers. Ann. Oncol.15(7), 1025–1032 (2004).
   PubMed Web of Science ®Google Scholar
• Okamoto M, Kasetani H, Kaji R et al. cis-Diamminedichloroplatinum and 5-fluorouracil are potent inducers of the cytokines and natural killer cell activity in vivo and in vitro. Cancer Immunol. Immunother.47(4), 233–241 (1998).
   PubMed Web of Science ®Google Scholar
• Vincent J, Mignot G, Chalmin F et al. 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res.70(8), 3052–3061 (2010).
   PubMed Web of Science ®Google Scholar
• Gnant MF, Puhlmann M, Alexander HR Jr, Bartlett DL. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice. Cancer Res.59(14), 3396–3403 (1999).
   PubMed Web of Science ®Google Scholar
• Chalikonda S, Kivlen MH, O’Malley ME et al. Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene. Cancer Gene Ther.15(2), 115–125 (2008).
   PubMed Web of Science ®Google Scholar
• Erbs P, Regulier E, Kintz J et al. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene. Cancer Res.60(14), 3813–3822 (2000).
   PubMed Web of Science ®Google Scholar
• Foloppe J, Kintz J, Futin N et al. Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus. Gene Ther.15(20), 1361–1371 (2008).
   PubMed Web of Science ®Google Scholar
• McCart JA, Ward JM, Lee J et al. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes. Cancer Res.61(24), 8751–8757 (2001).
   PubMed Web of Science ®Google Scholar
• Guo ZS, Naik A, O’Malley ME et al. The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2. Cancer Res.65(21), 9991–9998 (2005).
   PubMed Web of Science ®Google Scholar